DG Gel Essential Control 2x2x6ml
by Medion Grifols Diagnostics AG
DG Gel Essential Control 2x2x6ml (213288) is a multiple immunohaematology test IVD made by Medion Grifols Diagnostics AG, listed under FDA premarket submission BK180280 and listed in FDA GUDID since 23 Apr 2019 (UDI-DI 07640137341381), active as of 23 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
510(k) BK180280
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number07640137341381 | Date23 Apr 2019 | StatusListed |
| United States | FDA 510(k) | NumberBK180280 | Date— | StatusActive |
Official records
- AccessGUDID record 07640137341381
Across registries
- FDA premarket submission BK180280 Active
- FDA GUDID UDI-DI 07640137341381 listed 23 Apr 2019 Listed
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- DG Gel Essential Control
- Generic name
- Multiple immunohaematology test IVD, control
- Model / Ref / Catalog
- 2x2x6ml, 213288
- Primary DI / UDI-DI
- 07640137341381
- GMDN term
- Multiple immunohaematology test IVD, control
- GUDID distribution status
- In Commercial Distribution